Bioharmony Therapeutics
Entity

  • Bioharmony Therapeutics

    Created in 2016


  • To investigate (B)
    Some signals may appear as inconsistent with a regular activity

  • Social networks

    312 312

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    340 E 80th St, New York, NY 10075, USA

    New York

    United States of America

  • Employees

    Scale: 2-10

    Estimated: 1

  • SIREN

    959131970

  • Engaged catalyst

    2
    0 0

  • Added in Motherbase

    6 years, 7 months ago
Description
  • Value proposition

    At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.

Catalyst interactions
Catalyst TypeTweets Articles
KPMG
KPMG
Consulting, audit, Accounting
KPMG
Consulting, audit, Accounting 		Not capitalistic
Not partnership
Event

28 Sep 2021


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health 		Not capitalistic
Partnership
Event

4 Oct 2021


Social network dynamics
Similar entities
BETA
Last news
Show all articles